Oral Nasal Virucidal Therapy in Prevention and Treatment of COVID-19
The push for prophylaxis and treatment of SARS-CoV-2 oropharyngeal infection starts in the nose and mouth. A randomized trial by Choudhury et al. from Bangladesh has been overlooked by US public agencies but not the early treatment organizations around the world.
|McCullough et al. Reviews in Cardiovascular Medicine, 2020|